Ronald R. Nepomuceno
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Viral-associated cancers and disorders, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → cDNA Cloning and Primary Structure Analysis of C1qRP, the Human C1q/MBL/SPA Receptor That Mediates Enhanced Phagocytosis In Vitro(1997)254 cited
- → Human cytomegalovirus penetrates host cells by PH-independent fusion at the cell surface(1992)220 cited
- Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas.(2003)
- → C1qRP, the C1q Receptor That Enhances Phagocytosis, Is Detected Specifically in Human Cells of Myeloid Lineage, Endothelial Cells, and Platelets(1998)145 cited
- → Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis(2001)91 cited
- → Rapamycin Inhibits Proliferation of Epstein-Barr Virus–Positive B-cell Lymphomas Through Modulation of Cell-Cycle Protein Expression(2007)79 cited
- → C1qRP Is a Heavily O -Glycosylated Cell Surface Protein Involved in the Regulation of Phagocytic Activity(1999)72 cited
- → CryoEM Structure at 9 Å Resolution of an Adenovirus Vector Targeted to Hematopoietic Cells(2005)61 cited
- → Identification of 1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea Hydrochloride (CEP-32496), a Highly Potent and Orally Efficacious Inhibitor of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) V600E(2011)58 cited
- → CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity(2012)47 cited